Your shopping cart is currently empty

GNE-8324 is a GluN2A selective positive allosteric modulator that selectively enhances NMDAR-mediated synaptic responses in inhibitory, but not excitatory, neurons.GNE-8324 is used in the study of neurological disorders.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $153 | In Stock | In Stock | |
| 5 mg | $378 | In Stock | In Stock | |
| 10 mg | $559 | In Stock | In Stock | |
| 25 mg | $893 | In Stock | In Stock | |
| 50 mg | $1,180 | In Stock | In Stock | |
| 100 mg | $1,620 | In Stock | In Stock | |
| 200 mg | $2,180 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $387 | In Stock | In Stock |
| Description | GNE-8324 is a GluN2A selective positive allosteric modulator that selectively enhances NMDAR-mediated synaptic responses in inhibitory, but not excitatory, neurons.GNE-8324 is used in the study of neurological disorders. |
| In vitro | At GluN2A-type NMDARs, there is a reciprocal allosteric interaction between the binding sites for GNE-8324 and glutamate, meaning that glutamate binding promotes the binding of GNE-8324, and vice versa. GNE-8324 selectively enhances NMDARs containing the GluN2A subunit, with its potentiating effect significantly dependent on the occupancy of the glutamate site. The binding affinity of GNE-8324 is markedly higher in glutamate-bound NMDARs compared to those without bound glutamate. [1] |
| Synonyms | GNE8324, GNE 8324 |
| Molecular Weight | 343.42 |
| Formula | C18H18FN3OS |
| Cas No. | 1698901-76-6 |
| Smiles | O=C1C=C(N=C2SC3=C(N12)CCC3)CN(C4=CC=C(F)C=C4)CC |
| Relative Density. | no data available |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (232.95 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (11.65 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.